Dataset: Defective ribosomal protein gene expression alters transcription, translation, apoptosis, and oncogenic pathways in Diamond-Blackfan anemia.

Transcriptome profile of highly purified multipotential (P), erythroid (E), and myeloid (M) bone marrow progenitors from three RPS19...

Registered by ArrayExpress Uploader

View Dataset

Transcriptome profile of highly purified multipotential (P), erythroid (E), and myeloid (M) bone marrow progenitors from three RPS19 mutated Diamond-Blackfan anemia and six control human subjects. Two group comparison of sex and age matched subjects. Bone marrow progenitors, gene expression profiling, Diamond-Blackfan anemia, RPS19

Species:: human
Samples:: 27
Source:: E-GEOD-41599
PubMed:: 16741228
Updated:: Dec.12, 2014
Registered:: Jun.18, 2014

Factors: (via ArrayExpress)

Sample	SUBJECT ID	DISEASE STATUS	SEX	AGE	CELL TYPE
GSM1019956	D3	DiamondâBlackfan anemia	male	42 year old	multipotential P, CD34+, CD71â, CD45RAâ
GSM1019955	D3	DiamondâBlackfan anemia	male	42 year old	myeloid M, CD34+, CD71 low, CD45RA+
GSM1019954	D3	DiamondâBlackfan anemia	male	42 year old	erythroid E, CD34+, CD71 hi, CD45RAâ
GSM1019953	D2	DiamondâBlackfan anemia	male	30 year old	multipotential P, CD34+, CD71â, CD45RAâ
GSM1019952	D2	DiamondâBlackfan anemia	male	30 year old	myeloid M, CD34+, CD71 low, CD45RA+
GSM101995	D2	DiamondâBlackfan anemia	male	30 year old	erythroid E, CD34+, CD71 hi, CD45RAâ
GSM1019950	D1	DiamondâBlackfan anemia	female	46 year old	multipotential P, CD34+, CD71â, CD45RAâ
GSM1019949	D1	DiamondâBlackfan anemia	female	46 year old	myeloid M, CD34+, CD71 low, CD45RA+
GSM1019948	D1	DiamondâBlackfan anemia	female	46 year old	erythroid E, CD34+, CD71 hi, CD45RAâ
GSM1019947	C6	control	female	between 25 and 40 years old	multipotential P, CD34+, CD71â, CD45RAâ
GSM1019946	C6	control	female	between 25 and 40 years old	myeloid M, CD34+, CD71 low, CD45RA+
GSM1019945	C6	control	female	between 25 and 40 years old	erythroid E, CD34+, CD71 hi, CD45RAâ
GSM1019944	C5	control	female	between 25 and 40 years old	multipotential P, CD34+, CD71â, CD45RAâ
GSM1019943	C5	control	female	between 25 and 40 years old	myeloid M, CD34+, CD71 low, CD45RA+
GSM1019942	C5	control	female	between 25 and 40 years old	erythroid E, CD34+, CD71 hi, CD45RAâ
GSM101994	C4	control	female	between 25 and 40 years old	multipotential P, CD34+, CD71â, CD45RAâ
GSM1019940	C4	control	female	between 25 and 40 years old	myeloid M, CD34+, CD71 low, CD45RA+
GSM1019939	C4	control	female	between 25 and 40 years old	erythroid E, CD34+, CD71 hi, CD45RAâ
GSM1019938	C3	control	female	between 25 and 40 years old	multipotential P, CD34+, CD71â, CD45RAâ
GSM1019937	C3	control	female	between 25 and 40 years old	myeloid M, CD34+, CD71 low, CD45RA+
GSM1019936	C3	control	female	between 25 and 40 years old	erythroid E, CD34+, CD71 hi, CD45RAâ
GSM1019935	C2	control	male	between 25 and 40 years old	multipotential P, CD34+, CD71â, CD45RAâ
GSM1019934	C2	control	male	between 25 and 40 years old	myeloid M, CD34+, CD71 low, CD45RA+
GSM1019933	C2	control	male	between 25 and 40 years old	erythroid E, CD34+, CD71 hi, CD45RAâ
GSM1019932	C1	control	female	between 25 and 40 years old	multipotential P, CD34+, CD71â, CD45RAâ
GSM101993	C1	control	female	between 25 and 40 years old	myeloid M, CD34+, CD71 low, CD45RA+
GSM1019930	C1	control	female	between 25 and 40 years old	erythroid E, CD34+, CD71 hi, CD45RAâ